Article info

Download PDFPDF

Colchicine treatment in community healthcare setting to prevent severe COVID-19
Free

Authors

  • Emanuel Della-Torre Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milan, Italy Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Giuseppe A Ramirez Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milan, Italy Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Lorenzo Dagna Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milan, Italy Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Moreno Tresoldi Unit of General Medicine and Advanced Care, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Emanuel Della-Torre, Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milan, Italy; dellatorre.emanuel{at}hsr.it
View Full Text

Citation

Della-Torre E, Ramirez GA, Dagna L, et al
Colchicine treatment in community healthcare setting to prevent severe COVID-19

Publication history

  • Received July 31, 2020
  • Accepted August 2, 2020
  • First published August 27, 2020.
Online issue publication 
September 12, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.